SoftServe Unveils New Gen AI Solution ‘Drug Discovery,' Built with NVIDIA Blueprints at AWS re:Invent 2024

Core Insights - SoftServe has launched a new Generative AI solution for drug discovery in partnership with NVIDIA, aimed at accelerating drug development and making treatments more affordable [1][2][3] - The solution integrates NVIDIA's technologies to enhance molecular screening, reducing costs and improving efficiency in the early stages of drug discovery [2][3] - This launch marks the sixth Generative AI solution from SoftServe, which aims to democratize access to AI and speed up deployment in various applications [3] Company Overview - SoftServe is a leading IT consulting and digital services provider, focusing on innovative technologies to address complex business challenges [7][8] - The company has over 30 years of experience in delivering digital solutions across multiple industries, including healthcare, life sciences, and financial services [8] Event Context - The announcement was made during AWS re:Invent 2024, where SoftServe is showcasing its Generative AI solutions at the NVIDIA-sponsored booth [4]